Patents by Inventor Thomas Coleman
Thomas Coleman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240082540Abstract: Disclosed herein are catheters having multiple coil layers, and associated systems and methods. In some embodiments, a catheter includes an inner liner, a plurality of wires over the inner liner, and an outer sheath over the wires. The wires are coiled about a longitudinal axis of the catheter in a first direction to form a first coil layer over the inner liner, and the wires are coiled about the longitudinal axis in a second direction, opposite the first direction, over the first coil layer to form a second coil layer over the first coil layer. The wires each include a continuous/self-terminating end portion wherein the wire switches from the first direction to the second direction and transitions from the inner coil layer to the outer coil layer.Type: ApplicationFiled: September 8, 2023Publication date: March 14, 2024Inventors: Thomas Robert Brodt, John Coleman Thress, Benjamin Edward Merritt, Miguel Rendon Flores, Donald Joseph Fuller
-
Publication number: 20240074771Abstract: Systems and methods for the intravascular treatment of clot material within a blood vessel of a human patient are disclosed herein. A method in accordance with embodiments of the present technology can include, for example, engaging an interventional device of a catheter system with clot material in a blood vessel and withdrawing the interventional device and the portion of the clot material through a guide catheter. In some embodiments, the catheter system can include an attachment/valve member coupled to a proximal portion of the guide catheter, and the method can include unsealing the attachment/valve member to facilitate withdrawing the interventional device through the attachment/valve member without significant retention of clot material within the attachment/valve member. The method can further include resealing and aspirating the guide catheter before advancing another interventional device to the clot material to again engage and remove clot material from the blood vessel.Type: ApplicationFiled: October 30, 2023Publication date: March 7, 2024Inventors: Richard Quick, Benjamin Edward Merritt, John Coleman Thress, Paul Lubock, Thomas M. Tu
-
Publication number: 20220366148Abstract: A method and apparatus are provided for processing a set of communicated signals associated with a set of muscles, such as the muscles near the larynx of the person, or any other muscles the person use to achieve a desired response. The method includes the steps of attaching a single integrated sensor, for example, near the throat of the person proximate to the larynx and detecting an electrical signal through the sensor. The method further includes the steps of extracting features from the detected electrical signal and continuously transforming them into speech sounds without the need for further modulation. The method also includes comparing the extracted features to a set of prototype features and selecting a prototype feature of the set of prototype features providing a smallest relative difference.Type: ApplicationFiled: December 21, 2021Publication date: November 17, 2022Inventors: Michael Callahan, Thomas Coleman
-
Patent number: 11295253Abstract: Methods and apparatus for asset management are provided. The apparatus, for example, a processor to receive an input including intervention information for a first plurality of assets in a first circuit and for a second plurality of assets in a second circuit in a network; create a first plurality of bundling strategies for interventions to be performed for the first plurality of assets in the first circuit and create a second plurality of bundling strategies for interventions to be performed for the second plurality of assets in the second circuit; calculate for a created first plurality of bundling strategies and a created second plurality of bundling strategies at least one of an outage duration and cost associated with the interventions; and create a schedule for performing interventions for the first plurality of assets in the first circuit and the second plurality of assets in the second circuit.Type: GrantFiled: December 3, 2019Date of Patent: April 5, 2022Assignee: Copperleaf Technologies Inc.Inventors: Stanley Thomas Coleman, John Klippenstein, Alejandro Erickson, James Burberry
-
Patent number: 11205054Abstract: A method and apparatus are provided for processing a set of communicated signals associated with a set of muscles, such as the muscles near the larynx of the person, or any other muscles the person use to achieve a desired response. The method includes the steps of attaching a single integrated sensor, for example, near the throat of the person proximate to the larynx and detecting an electrical signal through the sensor. The method further includes the steps of extracting features from the detected electrical signal and continuously transforming them into speech sounds without the need for further modulation. The method also includes comparing the extracted features to a set of prototype features and selecting a prototype feature of the set of prototype features providing a smallest relative difference.Type: GrantFiled: December 18, 2018Date of Patent: December 21, 2021Inventors: Michael Callahan, Thomas Coleman
-
Publication number: 20210319513Abstract: A method, apparatus and system for portfolio performance prediction of a portfolio of projects include receiving information regarding at least start date delays, duration increases and cost overruns for at least one project of the portfolio of projects, determining at least one cluster for the at least one project from the received information regarding at least the start date delays, duration increases and cost overruns for the at least one project of the portfolio of projects, creating a statistical representation for each of the clusters of the at least one project of the portfolio, and predicting a performance of the portfolio of projects using information regarding the statistical representation of the clusters of the at least one project of the portfolio of projects.Type: ApplicationFiled: April 8, 2020Publication date: October 14, 2021Inventors: Danilo Prates de Oliveira, Stanley Thomas Coleman, Nicholas Sertic, William John Dall, Diego Andres Gonzalez Suarez
-
Patent number: 11096952Abstract: A method of treating an activated fibroblast associated disease or pre-disease condition in a mammal comprising, administering a pharmaceutical composition including a therapeutically effective amount of a first therapeutic, wherein the first therapeutic is one of an intracellular Ca2+ elevator, a YAP/TAZ inhibitor, both a intracellular Ca2+ elevator and a YAP/TAZ inhibitor, or pharmacologically acceptable salts, solvates, esters, amides, clathrates, stereoisomers, enantiomers, prodrugs or analogs thereof, or a combination thereof.Type: GrantFiled: February 2, 2017Date of Patent: August 24, 2021Assignee: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGEInventors: James Allen Cardelli, Charles Albert Stephens, Alana Lea Gray, David Thomas Coleman
-
Publication number: 20210166173Abstract: Methods and apparatus for asset management are provided. The apparatus, for example, a processor to receive an input including intervention information for a first plurality of assets in a first circuit and for a second plurality of assets in a second circuit in a network; create a first plurality of bundling strategies for interventions to be performed for the first plurality of assets in the first circuit and create a second plurality of bundling strategies for interventions to be performed for the second plurality of assets in the second circuit; calculate for a created first plurality of bundling strategies and a created second plurality of bundling strategies at least one of an outage duration and cost associated with the interventions; and create a schedule for performing interventions for the first plurality of assets in the first circuit and the second plurality of assets in the second circuit.Type: ApplicationFiled: December 3, 2019Publication date: June 3, 2021Inventors: Stanley Thomas Coleman, John Klippenstein, Alejandro Erickson, James Burberry
-
Patent number: 10980765Abstract: Products and methods for treating cancer in a human patient comprising administering to the patient therapeutically effective amount of a first pharmaceutically active agent, wherein the first pharmaceutically active agent is one of an isothiocyanatostilbene and a pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.Type: GrantFiled: August 15, 2016Date of Patent: April 20, 2021Assignees: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY, BOARD OF SUPERVISORS FOR THE UNIVERSITY OF LOUISIAInventors: Alana Lea Gray, James Cardelli, David Thomas Coleman, Khalid El-Sayed, Mohamed M. Mohyeldin
-
Publication number: 20210065138Abstract: Methods and apparatus for asset management is provided. The apparatus, for example, includes an input/output device; and a processor programmed to: receive an input from a user via the input/output device, the input including information relating to assets maintained by the user; determine, based on the input, if a second asset that has not failed should be bundled with a first asset that has one of failed or has a high probability of failure such that both the first asset and the second asset are replaced together; and upon receiving a request from a user, output a result of the determination to the user via one of a display of the input/output device or remote electronic device in communication with the asset management apparatus.Type: ApplicationFiled: September 3, 2019Publication date: March 4, 2021Inventors: Stanley Thomas Coleman, Thomas Stanley Coleman
-
Publication number: 20190121858Abstract: A method and apparatus are provided for processing a set of communicated signals associated with a set of muscles, such as the muscles near the larynx of the person, or any other muscles the person use to achieve a desired response. The method includes the steps of attaching a single integrated sensor, for example, near the throat of the person proximate to the larynx and detecting an electrical signal through the sensor. The method further includes the steps of extracting features from the detected electrical signal and continuously transforming them into speech sounds without the need for further modulation. The method also includes comparing the extracted features to a set of prototype features and selecting a prototype feature of the set of prototype features providing a smallest relative difference.Type: ApplicationFiled: December 18, 2018Publication date: April 25, 2019Inventors: Michael Callahan, Thomas Coleman
-
Publication number: 20190038655Abstract: A method of treating an activated fibroblast associated disease or pre-disease condition in a mammal comprising, administering a pharmaceutical composition including a therapeutically effective amount of a first therapeutic, wherein the first therapeutic is one of an intracellular Ca2+ elevator, a YAP/TAZ inhibitor, both a intracellular Ca2+ elevator and a YAP/TAZ inhibitor, or pharmacologically acceptable salts, solvates, esters, amides, clathrates, stereoisomers, enantiomers, prodrugs or analogs thereof, or a combination thereof.Type: ApplicationFiled: February 2, 2017Publication date: February 7, 2019Inventors: James Allen CARDELLI, Charles Albert STEPHENS, Alana Lea GRAY, David Thomas COLEMAN
-
Publication number: 20190016769Abstract: The present invention is directed to novel tissue protective peptides. The tissue protective peptides of the invention may bind to a tissue protective receptor complex. In particular, the present invention is drawn to tissue protective peptides derived from or sharing consensus sequences with portions of cytokine receptor ligands, including Erythropoietin (EPO), that are not involved in the binding of the ligand to the receptor complex, e.g., to the EPO receptor homodimer. Accordingly, the tissue protective peptides of the invention are derived from the amino acid sequences of regions of cytokine receptor ligands that are generally located on or within the region of the ligand protein that is opposite of the receptor complex, i.e., are generally derived from amino acid sequences of regions of the ligand protein that face away from the receptor complex while the ligand is bound to the receptor.Type: ApplicationFiled: September 25, 2018Publication date: January 17, 2019Applicant: Araim Pharmaceuticals, Inc.Inventors: Anthony Cerami, Michael Brines, Thomas Coleman
-
Publication number: 20190000791Abstract: Products and methods for treating cancer in a human patient comprising administering to the patient therapeutically effective amount of a first pharmaceutically active agent, wherein the first pharmaceutically active agent is one of an isothiocyanatostilbene and a pharmacologically acceptable salt, solvate, ester, amide, clathrate, stereoisomer, enantiomer, prodrug or analog thereof, or a combination thereof.Type: ApplicationFiled: August 15, 2016Publication date: January 3, 2019Inventors: Alana Lea GRAY, James CARDELLI, David Thomas COLEMAN, Khalid EL-SAYED, Mohamed M. MOHYELDIN
-
Patent number: 10162818Abstract: A method and apparatus are provided for processing a set of communicated signals associated with a set of muscles, such as the muscles near the larynx of the person, or any other muscles the person use to achieve a desired response. The method includes the steps of attaching a single integrated sensor, for example, near the throat of the person proximate to the larynx and detecting an electrical signal through the sensor. The method further includes the steps of extracting features from the detected electrical signal and continuously transforming them into speech sounds without the need for further modulation. The method also includes comparing the extracted features to a set of prototype features and selecting a prototype feature of the set of prototype features providing a smallest relative difference.Type: GrantFiled: May 4, 2017Date of Patent: December 25, 2018Assignee: Ambient CorporationInventors: Michael Callahan, Thomas Coleman
-
Patent number: 10100096Abstract: The present invention is directed to novel tissue protective peptides. The tissue protective peptides of the invention may bind to a tissue protective receptor complex. In particular, the present invention is drawn to tissue protective peptides derived from or sharing consensus sequences with portions of cytokine receptor ligands, including Erythropoietin (EPO), that are not involved in the binding of the ligand to the receptor complex, e.g., to the EPO receptor homodimer. Accordingly, the tissue protective peptides of the invention are derived from the amino acid sequences of regions of cytokine receptor ligands that are generally located on or within the region of the ligand protein that is opposite of the receptor complex, i.e., are generally derived from amino acid sequences of regions of the ligand protein that face away from the receptor complex while the ligand is bound to the receptor.Type: GrantFiled: May 5, 2016Date of Patent: October 16, 2018Assignee: Araim Pharmaceuticals, Inc.Inventors: Anthony Cerami, Michael Brines, Thomas Coleman
-
Publication number: 20180075019Abstract: A method and apparatus are provided for processing a set of communicated signals associated with a set of muscles, such as the muscles near the larynx of the person, or any other muscles the person use to achieve a desired response. The method includes the steps of attaching a single integrated sensor, for example, near the throat of the person proximate to the larynx and detecting an electrical signal through the sensor. The method further includes the steps of extracting features from the detected electrical signal and continuously transforming them into speech sounds without the need for further modulation. The method also includes comparing the extracted features to a set of prototype features and selecting a prototype feature of the set of prototype features providing a smallest relative difference.Type: ApplicationFiled: May 4, 2017Publication date: March 15, 2018Inventors: Michael Callahan, Thomas Coleman
-
Patent number: 9772997Abstract: A method and apparatus for processing a set of communicated signals associated with a set of muscles, such as the muscles near the larynx of the person, or any other muscles the person use to achieve a desired response. The method may include attaching a sensor near an area of a user's body associated with speech production, detecting an electrical signal from the user's nervous system through the sensor, and processing the detected electrical signal to provide communication capability for the user. The processing may include extracting a set of features of the detected electrical signal. The extracted set of features may be compared with a set of prototype features. The set of prototype features may correspond to at least one of multiple response classes. The multiple response classes may include an affirmative response class and a negative response class.Type: GrantFiled: February 2, 2015Date of Patent: September 26, 2017Assignee: Ambient CorporationInventors: Michael Callahan, Thomas Coleman
-
Patent number: 9679253Abstract: Apparatus and methods for managing and upgrading components in an infrastructure are provided. Records relating to components may be retrieved from a database and separated into subsets based on conditions of those components, the types of those components, deterioration models of those components, and/or other factors. Future condition values may be calculated for each subset, and likelihoods of failure of components may be determined for each subset based on those future condition values. The estimated condition values may be used in order to determine an optimal approach to maintaining, refurbishing, and/or replacing the components in the infrastructure. Computational efficiency is increased.Type: GrantFiled: October 5, 2015Date of Patent: June 13, 2017Assignee: Copperleaf Technologies Inc.Inventors: Giuseppe Gnocato, Nicholas James Malcolm, Stanley Thomas Coleman
-
Publication number: 20160244498Abstract: The present invention is directed to novel tissue protective peptides. The tissue protective peptides of the invention may bind to a tissue protective receptor complex. In particular, the present invention is drawn to tissue protective peptides derived from or sharing consensus sequences with portions of cytokine receptor ligands, including Erythropoietin (EPO), that are not involved in the binding of the ligand to the receptor complex, e.g., to the EPO receptor homodimer. Accordingly, the tissue protective peptides of the invention are derived from the amino acid sequences of regions of cytokine receptor ligands that are generally located on or within the region of the ligand protein that is opposite of the receptor complex, i.e., are generally derived from amino acid sequences of regions of the ligand protein that face away from the receptor complex while the ligand is bound to the receptor.Type: ApplicationFiled: May 5, 2016Publication date: August 25, 2016Applicant: Araim Pharmaceuticals, Inc.Inventors: Anthony Cerami, Michael Brines, Thomas Coleman